Global Comprehensive Genomic Profiling Supply, Demand and Key Producers, 2026-2032
The global Comprehensive Genomic Profiling market size is expected to reach $ 15343 million by 2032, rising at a market growth of 13.1% CAGR during the forecast period (2026-2032).
Comprehensive Genomic Profiling refers to clinical diagnostic and precision oncology solutions that use targeted next-generation sequencing, whole-exome sequencing, whole-transcriptome sequencing, or integrated DNA and RNA analysis to profile a broad range of cancer-related genes and molecular biomarkers. Major targets include single nucleotide variants, insertions and deletions, copy number alterations, gene fusions and rearrangements, as well as genomic signatures such as tumor mutational burden, microsatellite instability, and homologous recombination deficiency. Commercial offerings include centralized laboratory testing services, tissue and liquid biopsy assay kits, integrated testing systems, and associated bioinformatics solutions. These products are primarily used for targeted therapy selection, immunotherapy assessment, clinical trial matching, molecular classification, and resistance analysis. Key upstream inputs include specimen collection components, nucleic acid extraction and library preparation reagents, capture probes, amplification enzymes, sequencing flow cells, quality controls, reference standards, sequencing platforms, bioinformatics algorithms, and genomic databases. Major downstream customers include hospitals, cancer centers, independent clinical laboratories, pathology laboratories, pharmaceutical and biotechnology companies, and clinical research organizations. The estimated industry gross margin is generally approximately 50%?70%.
The global Comprehensive Genomic Profiling market is shifting rapidly from sequential single-gene testing toward integrated analysis of multiple genes and variant classes in a single assay. As the number of targeted therapies, immunotherapy biomarkers, and tumor-agnostic indications increases, sequential testing has become less efficient because of tissue consumption, longer turnaround times, and cumulative cost. Large genomic panels can evaluate multiple actionable alterations and complex genomic signatures in one test and are therefore gaining adoption among patients with advanced solid tumors, rare cancers, and limited standard treatment options. North America is dominated by centralized laboratory services, Europe and Japan rely more heavily on approved assay products and designated hospital networks, while China has developed a mixed structure combining third-party laboratories, hospital-based testing, and standardized domestic assay kits.
Tissue testing remains the foundation of Comprehensive Genomic Profiling, but liquid biopsy is becoming an important complementary option for patients with insufficient tissue, high biopsy risk, or a need for rapid results. Testing scope is expanding from targeted panels containing several hundred genes toward integrated DNA and RNA sequencing, matched tumor-normal analysis, whole-exome sequencing, and whole-transcriptome sequencing. RNA analysis improves the detection of gene fusions and abnormal splicing events, while matched-normal testing helps distinguish somatic alterations from germline variants and clonal hematopoiesis signals. Future competition will focus increasingly on performance in low-tumor-content specimens, fusion detection, turnaround time, clinical evidence, and the actionability of reported findings rather than on gene count alone.
Market growth is supported by the continued expansion of precision oncology, increasing numbers of tumor-agnostic targeted and immunotherapy indications, stronger clinical guideline recommendations, and broader availability of hospital NGS infrastructure. Drug development is gradually shifting from organ-of-origin classification toward molecular biomarker-driven patient selection. Pharmaceutical demand for companion diagnostics, patient screening, clinical trial matching, and real-world evidence provides testing companies with important revenue opportunities beyond routine patient testing. As sequencing costs decline, laboratory workflows become more automated, and reimbursement coverage improves in selected markets, Comprehensive Genomic Profiling is expected to expand from late-stage and rare cases toward earlier treatment stages and a broader patient population.
The industry nevertheless faces constraints related to specimen quality, testing costs, reimbursement, and the clinical conversion of genomic findings. Differences in gene coverage, sequencing depth, variant thresholds, and reporting rules may produce inconsistent results across laboratories. Some patients have potentially actionable alterations but cannot access matched treatment because of drug availability, regulatory indications, or the geographic location of relevant clinical trials. Competition between hospital-developed assays and centralized laboratory services may also place pressure on testing prices and lead to duplicated infrastructure investment. Future competitive advantage will increasingly depend on regulatory approvals, companion diagnostic partnerships, liquid biopsy performance, clinical interpretation capabilities, reimbursement access, and real-world evidence demonstrating clinical utility.
This report studies the global Comprehensive Genomic Profiling demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Comprehensive Genomic Profiling, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Comprehensive Genomic Profiling that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Comprehensive Genomic Profiling total market, 2021-2032, (USD Million)
Global Comprehensive Genomic Profiling total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Comprehensive Genomic Profiling total market, key domestic companies, and share, (USD Million)
Global Comprehensive Genomic Profiling revenue by player, revenue and market share 2021-2026, (USD Million)
Global Comprehensive Genomic Profiling total market by Type, CAGR, 2021-2032, (USD Million)
Global Comprehensive Genomic Profiling total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Comprehensive Genomic Profiling market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Guardant Health, Caris Life Sciences, Tempus AI, Labcorp, NeoGenomics, Exact Sciences, Personalis, Illumina, Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Comprehensive Genomic Profiling market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Comprehensive Genomic Profiling Market, By Region:
1. How big is the global Comprehensive Genomic Profiling market?
2. What is the demand of the global Comprehensive Genomic Profiling market?
3. What is the year over year growth of the global Comprehensive Genomic Profiling market?
4. What is the total value of the global Comprehensive Genomic Profiling market?
5. Who are the Major Players in the global Comprehensive Genomic Profiling market?
6. What are the growth factors driving the market demand?
Comprehensive Genomic Profiling refers to clinical diagnostic and precision oncology solutions that use targeted next-generation sequencing, whole-exome sequencing, whole-transcriptome sequencing, or integrated DNA and RNA analysis to profile a broad range of cancer-related genes and molecular biomarkers. Major targets include single nucleotide variants, insertions and deletions, copy number alterations, gene fusions and rearrangements, as well as genomic signatures such as tumor mutational burden, microsatellite instability, and homologous recombination deficiency. Commercial offerings include centralized laboratory testing services, tissue and liquid biopsy assay kits, integrated testing systems, and associated bioinformatics solutions. These products are primarily used for targeted therapy selection, immunotherapy assessment, clinical trial matching, molecular classification, and resistance analysis. Key upstream inputs include specimen collection components, nucleic acid extraction and library preparation reagents, capture probes, amplification enzymes, sequencing flow cells, quality controls, reference standards, sequencing platforms, bioinformatics algorithms, and genomic databases. Major downstream customers include hospitals, cancer centers, independent clinical laboratories, pathology laboratories, pharmaceutical and biotechnology companies, and clinical research organizations. The estimated industry gross margin is generally approximately 50%?70%.
The global Comprehensive Genomic Profiling market is shifting rapidly from sequential single-gene testing toward integrated analysis of multiple genes and variant classes in a single assay. As the number of targeted therapies, immunotherapy biomarkers, and tumor-agnostic indications increases, sequential testing has become less efficient because of tissue consumption, longer turnaround times, and cumulative cost. Large genomic panels can evaluate multiple actionable alterations and complex genomic signatures in one test and are therefore gaining adoption among patients with advanced solid tumors, rare cancers, and limited standard treatment options. North America is dominated by centralized laboratory services, Europe and Japan rely more heavily on approved assay products and designated hospital networks, while China has developed a mixed structure combining third-party laboratories, hospital-based testing, and standardized domestic assay kits.
Tissue testing remains the foundation of Comprehensive Genomic Profiling, but liquid biopsy is becoming an important complementary option for patients with insufficient tissue, high biopsy risk, or a need for rapid results. Testing scope is expanding from targeted panels containing several hundred genes toward integrated DNA and RNA sequencing, matched tumor-normal analysis, whole-exome sequencing, and whole-transcriptome sequencing. RNA analysis improves the detection of gene fusions and abnormal splicing events, while matched-normal testing helps distinguish somatic alterations from germline variants and clonal hematopoiesis signals. Future competition will focus increasingly on performance in low-tumor-content specimens, fusion detection, turnaround time, clinical evidence, and the actionability of reported findings rather than on gene count alone.
Market growth is supported by the continued expansion of precision oncology, increasing numbers of tumor-agnostic targeted and immunotherapy indications, stronger clinical guideline recommendations, and broader availability of hospital NGS infrastructure. Drug development is gradually shifting from organ-of-origin classification toward molecular biomarker-driven patient selection. Pharmaceutical demand for companion diagnostics, patient screening, clinical trial matching, and real-world evidence provides testing companies with important revenue opportunities beyond routine patient testing. As sequencing costs decline, laboratory workflows become more automated, and reimbursement coverage improves in selected markets, Comprehensive Genomic Profiling is expected to expand from late-stage and rare cases toward earlier treatment stages and a broader patient population.
The industry nevertheless faces constraints related to specimen quality, testing costs, reimbursement, and the clinical conversion of genomic findings. Differences in gene coverage, sequencing depth, variant thresholds, and reporting rules may produce inconsistent results across laboratories. Some patients have potentially actionable alterations but cannot access matched treatment because of drug availability, regulatory indications, or the geographic location of relevant clinical trials. Competition between hospital-developed assays and centralized laboratory services may also place pressure on testing prices and lead to duplicated infrastructure investment. Future competitive advantage will increasingly depend on regulatory approvals, companion diagnostic partnerships, liquid biopsy performance, clinical interpretation capabilities, reimbursement access, and real-world evidence demonstrating clinical utility.
This report studies the global Comprehensive Genomic Profiling demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Comprehensive Genomic Profiling, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Comprehensive Genomic Profiling that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Comprehensive Genomic Profiling total market, 2021-2032, (USD Million)
Global Comprehensive Genomic Profiling total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Comprehensive Genomic Profiling total market, key domestic companies, and share, (USD Million)
Global Comprehensive Genomic Profiling revenue by player, revenue and market share 2021-2026, (USD Million)
Global Comprehensive Genomic Profiling total market by Type, CAGR, 2021-2032, (USD Million)
Global Comprehensive Genomic Profiling total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Comprehensive Genomic Profiling market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Guardant Health, Caris Life Sciences, Tempus AI, Labcorp, NeoGenomics, Exact Sciences, Personalis, Illumina, Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Comprehensive Genomic Profiling market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Comprehensive Genomic Profiling Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tissue-based Profiling
- Liquid Biopsy Profiling
- Other
- Medium Panels (50?199 Genes)
- Large Panels (200?599 Genes)
- Extended Panels (600?999 Genes)
- Other
- Targeted DNA Sequencing
- Integrated DNA and RNA Sequencing
- Whole-exome Sequencing
- Whole-transcriptome Sequencing
- Other
- Hospitals and Cancer Centers
- Independent Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Other
- Roche
- Guardant Health
- Caris Life Sciences
- Tempus AI
- Labcorp
- NeoGenomics
- Exact Sciences
- Personalis
- Illumina
- Thermo Fisher Scientific
- QIAGEN
- Agilent Technologies
- SOPHiA GENETICS
- Sysmex
- Burning Rock Biotech
- Genetron Health
- Geneseeq
- BGI Genomics
- Amoy Diagnostics
1. How big is the global Comprehensive Genomic Profiling market?
2. What is the demand of the global Comprehensive Genomic Profiling market?
3. What is the year over year growth of the global Comprehensive Genomic Profiling market?
4. What is the total value of the global Comprehensive Genomic Profiling market?
5. Who are the Major Players in the global Comprehensive Genomic Profiling market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Comprehensive Genomic Profiling Introduction
1.2 World Comprehensive Genomic Profiling Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Comprehensive Genomic Profiling Total Market by Region (by Headquarter Location)
1.3.1 World Comprehensive Genomic Profiling Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.3 China Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.4 Europe Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.5 Japan Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.6 South Korea Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.7 ASEAN Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.8 India Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Comprehensive Genomic Profiling Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.2 World Comprehensive Genomic Profiling Consumption Value by Region
2.2.1 World Comprehensive Genomic Profiling Consumption Value by Region (2021-2026)
2.2.2 World Comprehensive Genomic Profiling Consumption Value Forecast by Region (2027-2032)
2.3 United States Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.4 China Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.5 Europe Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.6 Japan Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.7 South Korea Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.8 ASEAN Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.9 India Comprehensive Genomic Profiling Consumption Value (2021-2032)
3 WORLD COMPREHENSIVE GENOMIC PROFILING COMPANIES COMPETITIVE ANALYSIS
3.1 World Comprehensive Genomic Profiling Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Comprehensive Genomic Profiling Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Comprehensive Genomic Profiling in 2025
3.2.3 Global Concentration Ratios (CR8) for Comprehensive Genomic Profiling in 2025
3.3 Comprehensive Genomic Profiling Company Evaluation Quadrant
3.4 Comprehensive Genomic Profiling Market: Overall Company Footprint Analysis
3.4.1 Comprehensive Genomic Profiling Market: Region Footprint
3.4.2 Comprehensive Genomic Profiling Market: Company Product Type Footprint
3.4.3 Comprehensive Genomic Profiling Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Comprehensive Genomic Profiling Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Comprehensive Genomic Profiling Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Comprehensive Genomic Profiling Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Comprehensive Genomic Profiling Consumption Value Comparison
4.2.1 United States VS China: Comprehensive Genomic Profiling Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Comprehensive Genomic Profiling Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Comprehensive Genomic Profiling Companies and Market Share, 2021-2026
4.3.1 United States Based Comprehensive Genomic Profiling Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026)
4.4 China Based Companies Comprehensive Genomic Profiling Revenue and Market Share, 2021-2026
4.4.1 China Based Comprehensive Genomic Profiling Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026)
4.5 Rest of World Based Comprehensive Genomic Profiling Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Comprehensive Genomic Profiling Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Comprehensive Genomic Profiling Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tissue-based Profiling
5.2.2 Liquid Biopsy Profiling
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Comprehensive Genomic Profiling Market Size by Type (2021-2026)
5.3.2 World Comprehensive Genomic Profiling Market Size by Type (2027-2032)
5.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TESTING SCOPE
6.1 World Comprehensive Genomic Profiling Market Size Overview by Testing Scope: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Testing Scope
6.2.1 Medium Panels (50?199 Genes)
6.2.2 Large Panels (200?599 Genes)
6.2.3 Extended Panels (600?999 Genes)
6.2.4 Other
6.3 Market Segment by Testing Scope
6.3.1 World Comprehensive Genomic Profiling Market Size by Testing Scope (2021-2026)
6.3.2 World Comprehensive Genomic Profiling Market Size by Testing Scope (2027-2032)
6.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope (2027-2032)
7 MARKET ANALYSIS BY SEQUENCING APPROACH
7.1 World Comprehensive Genomic Profiling Market Size Overview by Sequencing Approach: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sequencing Approach
7.2.1 Targeted DNA Sequencing
7.2.2 Integrated DNA and RNA Sequencing
7.2.3 Whole-exome Sequencing
7.2.4 Whole-transcriptome Sequencing
7.2.5 Other
7.3 Market Segment by Sequencing Approach
7.3.1 World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2021-2026)
7.3.2 World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2027-2032)
7.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Comprehensive Genomic Profiling Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Cancer Centers
8.2.2 Independent Clinical Laboratories
8.2.3 Pharmaceutical and Biotechnology Companies
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Comprehensive Genomic Profiling Market Size by Application (2021-2026)
8.3.2 World Comprehensive Genomic Profiling Market Size by Application (2027-2032)
8.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Comprehensive Genomic Profiling Product and Services
9.1.4 Roche Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Guardant Health
9.2.1 Guardant Health Details
9.2.2 Guardant Health Major Business
9.2.3 Guardant Health Comprehensive Genomic Profiling Product and Services
9.2.4 Guardant Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guardant Health Recent Developments/Updates
9.2.6 Guardant Health Competitive Strengths & Weaknesses
9.3 Caris Life Sciences
9.3.1 Caris Life Sciences Details
9.3.2 Caris Life Sciences Major Business
9.3.3 Caris Life Sciences Comprehensive Genomic Profiling Product and Services
9.3.4 Caris Life Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Caris Life Sciences Recent Developments/Updates
9.3.6 Caris Life Sciences Competitive Strengths & Weaknesses
9.4 Tempus AI
9.4.1 Tempus AI Details
9.4.2 Tempus AI Major Business
9.4.3 Tempus AI Comprehensive Genomic Profiling Product and Services
9.4.4 Tempus AI Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Tempus AI Recent Developments/Updates
9.4.6 Tempus AI Competitive Strengths & Weaknesses
9.5 Labcorp
9.5.1 Labcorp Details
9.5.2 Labcorp Major Business
9.5.3 Labcorp Comprehensive Genomic Profiling Product and Services
9.5.4 Labcorp Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Labcorp Recent Developments/Updates
9.5.6 Labcorp Competitive Strengths & Weaknesses
9.6 NeoGenomics
9.6.1 NeoGenomics Details
9.6.2 NeoGenomics Major Business
9.6.3 NeoGenomics Comprehensive Genomic Profiling Product and Services
9.6.4 NeoGenomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 NeoGenomics Recent Developments/Updates
9.6.6 NeoGenomics Competitive Strengths & Weaknesses
9.7 Exact Sciences
9.7.1 Exact Sciences Details
9.7.2 Exact Sciences Major Business
9.7.3 Exact Sciences Comprehensive Genomic Profiling Product and Services
9.7.4 Exact Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Exact Sciences Recent Developments/Updates
9.7.6 Exact Sciences Competitive Strengths & Weaknesses
9.8 Personalis
9.8.1 Personalis Details
9.8.2 Personalis Major Business
9.8.3 Personalis Comprehensive Genomic Profiling Product and Services
9.8.4 Personalis Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Personalis Recent Developments/Updates
9.8.6 Personalis Competitive Strengths & Weaknesses
9.9 Illumina
9.9.1 Illumina Details
9.9.2 Illumina Major Business
9.9.3 Illumina Comprehensive Genomic Profiling Product and Services
9.9.4 Illumina Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Illumina Recent Developments/Updates
9.9.6 Illumina Competitive Strengths & Weaknesses
9.10 Thermo Fisher Scientific
9.10.1 Thermo Fisher Scientific Details
9.10.2 Thermo Fisher Scientific Major Business
9.10.3 Thermo Fisher Scientific Comprehensive Genomic Profiling Product and Services
9.10.4 Thermo Fisher Scientific Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Thermo Fisher Scientific Recent Developments/Updates
9.10.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.11 QIAGEN
9.11.1 QIAGEN Details
9.11.2 QIAGEN Major Business
9.11.3 QIAGEN Comprehensive Genomic Profiling Product and Services
9.11.4 QIAGEN Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 QIAGEN Recent Developments/Updates
9.11.6 QIAGEN Competitive Strengths & Weaknesses
9.12 Agilent Technologies
9.12.1 Agilent Technologies Details
9.12.2 Agilent Technologies Major Business
9.12.3 Agilent Technologies Comprehensive Genomic Profiling Product and Services
9.12.4 Agilent Technologies Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Agilent Technologies Recent Developments/Updates
9.12.6 Agilent Technologies Competitive Strengths & Weaknesses
9.13 SOPHiA GENETICS
9.13.1 SOPHiA GENETICS Details
9.13.2 SOPHiA GENETICS Major Business
9.13.3 SOPHiA GENETICS Comprehensive Genomic Profiling Product and Services
9.13.4 SOPHiA GENETICS Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 SOPHiA GENETICS Recent Developments/Updates
9.13.6 SOPHiA GENETICS Competitive Strengths & Weaknesses
9.14 Sysmex
9.14.1 Sysmex Details
9.14.2 Sysmex Major Business
9.14.3 Sysmex Comprehensive Genomic Profiling Product and Services
9.14.4 Sysmex Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sysmex Recent Developments/Updates
9.14.6 Sysmex Competitive Strengths & Weaknesses
9.15 Burning Rock Biotech
9.15.1 Burning Rock Biotech Details
9.15.2 Burning Rock Biotech Major Business
9.15.3 Burning Rock Biotech Comprehensive Genomic Profiling Product and Services
9.15.4 Burning Rock Biotech Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Burning Rock Biotech Recent Developments/Updates
9.15.6 Burning Rock Biotech Competitive Strengths & Weaknesses
9.16 Genetron Health
9.16.1 Genetron Health Details
9.16.2 Genetron Health Major Business
9.16.3 Genetron Health Comprehensive Genomic Profiling Product and Services
9.16.4 Genetron Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Genetron Health Recent Developments/Updates
9.16.6 Genetron Health Competitive Strengths & Weaknesses
9.17 Geneseeq
9.17.1 Geneseeq Details
9.17.2 Geneseeq Major Business
9.17.3 Geneseeq Comprehensive Genomic Profiling Product and Services
9.17.4 Geneseeq Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Geneseeq Recent Developments/Updates
9.17.6 Geneseeq Competitive Strengths & Weaknesses
9.18 BGI Genomics
9.18.1 BGI Genomics Details
9.18.2 BGI Genomics Major Business
9.18.3 BGI Genomics Comprehensive Genomic Profiling Product and Services
9.18.4 BGI Genomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 BGI Genomics Recent Developments/Updates
9.18.6 BGI Genomics Competitive Strengths & Weaknesses
9.19 Amoy Diagnostics
9.19.1 Amoy Diagnostics Details
9.19.2 Amoy Diagnostics Major Business
9.19.3 Amoy Diagnostics Comprehensive Genomic Profiling Product and Services
9.19.4 Amoy Diagnostics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Amoy Diagnostics Recent Developments/Updates
9.19.6 Amoy Diagnostics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Comprehensive Genomic Profiling Industry Chain
10.2 Comprehensive Genomic Profiling Upstream Analysis
10.3 Comprehensive Genomic Profiling Midstream Analysis
10.4 Comprehensive Genomic Profiling Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Comprehensive Genomic Profiling Introduction
1.2 World Comprehensive Genomic Profiling Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Comprehensive Genomic Profiling Total Market by Region (by Headquarter Location)
1.3.1 World Comprehensive Genomic Profiling Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.3 China Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.4 Europe Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.5 Japan Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.6 South Korea Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.7 ASEAN Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.3.8 India Based Company Comprehensive Genomic Profiling Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Comprehensive Genomic Profiling Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.2 World Comprehensive Genomic Profiling Consumption Value by Region
2.2.1 World Comprehensive Genomic Profiling Consumption Value by Region (2021-2026)
2.2.2 World Comprehensive Genomic Profiling Consumption Value Forecast by Region (2027-2032)
2.3 United States Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.4 China Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.5 Europe Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.6 Japan Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.7 South Korea Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.8 ASEAN Comprehensive Genomic Profiling Consumption Value (2021-2032)
2.9 India Comprehensive Genomic Profiling Consumption Value (2021-2032)
3 WORLD COMPREHENSIVE GENOMIC PROFILING COMPANIES COMPETITIVE ANALYSIS
3.1 World Comprehensive Genomic Profiling Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Comprehensive Genomic Profiling Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Comprehensive Genomic Profiling in 2025
3.2.3 Global Concentration Ratios (CR8) for Comprehensive Genomic Profiling in 2025
3.3 Comprehensive Genomic Profiling Company Evaluation Quadrant
3.4 Comprehensive Genomic Profiling Market: Overall Company Footprint Analysis
3.4.1 Comprehensive Genomic Profiling Market: Region Footprint
3.4.2 Comprehensive Genomic Profiling Market: Company Product Type Footprint
3.4.3 Comprehensive Genomic Profiling Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Comprehensive Genomic Profiling Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Comprehensive Genomic Profiling Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Comprehensive Genomic Profiling Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Comprehensive Genomic Profiling Consumption Value Comparison
4.2.1 United States VS China: Comprehensive Genomic Profiling Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Comprehensive Genomic Profiling Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Comprehensive Genomic Profiling Companies and Market Share, 2021-2026
4.3.1 United States Based Comprehensive Genomic Profiling Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026)
4.4 China Based Companies Comprehensive Genomic Profiling Revenue and Market Share, 2021-2026
4.4.1 China Based Comprehensive Genomic Profiling Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026)
4.5 Rest of World Based Comprehensive Genomic Profiling Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Comprehensive Genomic Profiling Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Comprehensive Genomic Profiling Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Tissue-based Profiling
5.2.2 Liquid Biopsy Profiling
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Comprehensive Genomic Profiling Market Size by Type (2021-2026)
5.3.2 World Comprehensive Genomic Profiling Market Size by Type (2027-2032)
5.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TESTING SCOPE
6.1 World Comprehensive Genomic Profiling Market Size Overview by Testing Scope: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Testing Scope
6.2.1 Medium Panels (50?199 Genes)
6.2.2 Large Panels (200?599 Genes)
6.2.3 Extended Panels (600?999 Genes)
6.2.4 Other
6.3 Market Segment by Testing Scope
6.3.1 World Comprehensive Genomic Profiling Market Size by Testing Scope (2021-2026)
6.3.2 World Comprehensive Genomic Profiling Market Size by Testing Scope (2027-2032)
6.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope (2027-2032)
7 MARKET ANALYSIS BY SEQUENCING APPROACH
7.1 World Comprehensive Genomic Profiling Market Size Overview by Sequencing Approach: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sequencing Approach
7.2.1 Targeted DNA Sequencing
7.2.2 Integrated DNA and RNA Sequencing
7.2.3 Whole-exome Sequencing
7.2.4 Whole-transcriptome Sequencing
7.2.5 Other
7.3 Market Segment by Sequencing Approach
7.3.1 World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2021-2026)
7.3.2 World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2027-2032)
7.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Comprehensive Genomic Profiling Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals and Cancer Centers
8.2.2 Independent Clinical Laboratories
8.2.3 Pharmaceutical and Biotechnology Companies
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Comprehensive Genomic Profiling Market Size by Application (2021-2026)
8.3.2 World Comprehensive Genomic Profiling Market Size by Application (2027-2032)
8.3.3 World Comprehensive Genomic Profiling Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Roche
9.1.1 Roche Details
9.1.2 Roche Major Business
9.1.3 Roche Comprehensive Genomic Profiling Product and Services
9.1.4 Roche Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Roche Recent Developments/Updates
9.1.6 Roche Competitive Strengths & Weaknesses
9.2 Guardant Health
9.2.1 Guardant Health Details
9.2.2 Guardant Health Major Business
9.2.3 Guardant Health Comprehensive Genomic Profiling Product and Services
9.2.4 Guardant Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guardant Health Recent Developments/Updates
9.2.6 Guardant Health Competitive Strengths & Weaknesses
9.3 Caris Life Sciences
9.3.1 Caris Life Sciences Details
9.3.2 Caris Life Sciences Major Business
9.3.3 Caris Life Sciences Comprehensive Genomic Profiling Product and Services
9.3.4 Caris Life Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Caris Life Sciences Recent Developments/Updates
9.3.6 Caris Life Sciences Competitive Strengths & Weaknesses
9.4 Tempus AI
9.4.1 Tempus AI Details
9.4.2 Tempus AI Major Business
9.4.3 Tempus AI Comprehensive Genomic Profiling Product and Services
9.4.4 Tempus AI Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Tempus AI Recent Developments/Updates
9.4.6 Tempus AI Competitive Strengths & Weaknesses
9.5 Labcorp
9.5.1 Labcorp Details
9.5.2 Labcorp Major Business
9.5.3 Labcorp Comprehensive Genomic Profiling Product and Services
9.5.4 Labcorp Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Labcorp Recent Developments/Updates
9.5.6 Labcorp Competitive Strengths & Weaknesses
9.6 NeoGenomics
9.6.1 NeoGenomics Details
9.6.2 NeoGenomics Major Business
9.6.3 NeoGenomics Comprehensive Genomic Profiling Product and Services
9.6.4 NeoGenomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 NeoGenomics Recent Developments/Updates
9.6.6 NeoGenomics Competitive Strengths & Weaknesses
9.7 Exact Sciences
9.7.1 Exact Sciences Details
9.7.2 Exact Sciences Major Business
9.7.3 Exact Sciences Comprehensive Genomic Profiling Product and Services
9.7.4 Exact Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Exact Sciences Recent Developments/Updates
9.7.6 Exact Sciences Competitive Strengths & Weaknesses
9.8 Personalis
9.8.1 Personalis Details
9.8.2 Personalis Major Business
9.8.3 Personalis Comprehensive Genomic Profiling Product and Services
9.8.4 Personalis Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Personalis Recent Developments/Updates
9.8.6 Personalis Competitive Strengths & Weaknesses
9.9 Illumina
9.9.1 Illumina Details
9.9.2 Illumina Major Business
9.9.3 Illumina Comprehensive Genomic Profiling Product and Services
9.9.4 Illumina Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Illumina Recent Developments/Updates
9.9.6 Illumina Competitive Strengths & Weaknesses
9.10 Thermo Fisher Scientific
9.10.1 Thermo Fisher Scientific Details
9.10.2 Thermo Fisher Scientific Major Business
9.10.3 Thermo Fisher Scientific Comprehensive Genomic Profiling Product and Services
9.10.4 Thermo Fisher Scientific Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Thermo Fisher Scientific Recent Developments/Updates
9.10.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.11 QIAGEN
9.11.1 QIAGEN Details
9.11.2 QIAGEN Major Business
9.11.3 QIAGEN Comprehensive Genomic Profiling Product and Services
9.11.4 QIAGEN Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 QIAGEN Recent Developments/Updates
9.11.6 QIAGEN Competitive Strengths & Weaknesses
9.12 Agilent Technologies
9.12.1 Agilent Technologies Details
9.12.2 Agilent Technologies Major Business
9.12.3 Agilent Technologies Comprehensive Genomic Profiling Product and Services
9.12.4 Agilent Technologies Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Agilent Technologies Recent Developments/Updates
9.12.6 Agilent Technologies Competitive Strengths & Weaknesses
9.13 SOPHiA GENETICS
9.13.1 SOPHiA GENETICS Details
9.13.2 SOPHiA GENETICS Major Business
9.13.3 SOPHiA GENETICS Comprehensive Genomic Profiling Product and Services
9.13.4 SOPHiA GENETICS Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 SOPHiA GENETICS Recent Developments/Updates
9.13.6 SOPHiA GENETICS Competitive Strengths & Weaknesses
9.14 Sysmex
9.14.1 Sysmex Details
9.14.2 Sysmex Major Business
9.14.3 Sysmex Comprehensive Genomic Profiling Product and Services
9.14.4 Sysmex Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Sysmex Recent Developments/Updates
9.14.6 Sysmex Competitive Strengths & Weaknesses
9.15 Burning Rock Biotech
9.15.1 Burning Rock Biotech Details
9.15.2 Burning Rock Biotech Major Business
9.15.3 Burning Rock Biotech Comprehensive Genomic Profiling Product and Services
9.15.4 Burning Rock Biotech Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Burning Rock Biotech Recent Developments/Updates
9.15.6 Burning Rock Biotech Competitive Strengths & Weaknesses
9.16 Genetron Health
9.16.1 Genetron Health Details
9.16.2 Genetron Health Major Business
9.16.3 Genetron Health Comprehensive Genomic Profiling Product and Services
9.16.4 Genetron Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Genetron Health Recent Developments/Updates
9.16.6 Genetron Health Competitive Strengths & Weaknesses
9.17 Geneseeq
9.17.1 Geneseeq Details
9.17.2 Geneseeq Major Business
9.17.3 Geneseeq Comprehensive Genomic Profiling Product and Services
9.17.4 Geneseeq Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Geneseeq Recent Developments/Updates
9.17.6 Geneseeq Competitive Strengths & Weaknesses
9.18 BGI Genomics
9.18.1 BGI Genomics Details
9.18.2 BGI Genomics Major Business
9.18.3 BGI Genomics Comprehensive Genomic Profiling Product and Services
9.18.4 BGI Genomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 BGI Genomics Recent Developments/Updates
9.18.6 BGI Genomics Competitive Strengths & Weaknesses
9.19 Amoy Diagnostics
9.19.1 Amoy Diagnostics Details
9.19.2 Amoy Diagnostics Major Business
9.19.3 Amoy Diagnostics Comprehensive Genomic Profiling Product and Services
9.19.4 Amoy Diagnostics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Amoy Diagnostics Recent Developments/Updates
9.19.6 Amoy Diagnostics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Comprehensive Genomic Profiling Industry Chain
10.2 Comprehensive Genomic Profiling Upstream Analysis
10.3 Comprehensive Genomic Profiling Midstream Analysis
10.4 Comprehensive Genomic Profiling Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Comprehensive Genomic Profiling Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Comprehensive Genomic Profiling Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Comprehensive Genomic Profiling Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Comprehensive Genomic Profiling Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Comprehensive Genomic Profiling Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Comprehensive Genomic Profiling Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Comprehensive Genomic Profiling Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Comprehensive Genomic Profiling Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Comprehensive Genomic Profiling Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Comprehensive Genomic Profiling Players in 2025
Table 12. World Comprehensive Genomic Profiling Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Comprehensive Genomic Profiling Company Evaluation Quadrant
Table 14. Head Office of Key Comprehensive Genomic Profiling Players
Table 15. Comprehensive Genomic Profiling Market: Company Product Type Footprint
Table 16. Comprehensive Genomic Profiling Market: Company Product Application Footprint
Table 17. Comprehensive Genomic Profiling Mergers & Acquisitions Activity
Table 18. United States VS China Comprehensive Genomic Profiling Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Comprehensive Genomic Profiling Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Comprehensive Genomic Profiling Companies, Headquarters (States, Country)
Table 21. United States Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 23. China Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
Table 24. China Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 26. Rest of World Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Comprehensive Genomic Profiling Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 29. World Comprehensive Genomic Profiling Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Comprehensive Genomic Profiling Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Comprehensive Genomic Profiling Market Size by Type (2027-2032) & (USD Million)
Table 32. World Comprehensive Genomic Profiling Market Size by Testing Scope, (USD Million), 2021 & 2025 & 2032
Table 33. World Comprehensive Genomic Profiling Market Size Value by Testing Scope (2021-2026) & (USD Million)
Table 34. World Comprehensive Genomic Profiling Market Size by Testing Scope (2027-2032) & (USD Million)
Table 35. World Comprehensive Genomic Profiling Market Size by Sequencing Approach, (USD Million), 2021 & 2025 & 2032
Table 36. World Comprehensive Genomic Profiling Market Size Value by Sequencing Approach (2021-2026) & (USD Million)
Table 37. World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2027-2032) & (USD Million)
Table 38. World Comprehensive Genomic Profiling Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Comprehensive Genomic Profiling Market Size by Application (2021-2026) & (USD Million)
Table 40. World Comprehensive Genomic Profiling Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Comprehensive Genomic Profiling Product and Services
Table 44. Roche Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 48. Guardant Health Major Business
Table 49. Guardant Health Comprehensive Genomic Profiling Product and Services
Table 50. Guardant Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guardant Health Recent Developments/Updates
Table 52. Guardant Health Competitive Strengths & Weaknesses
Table 53. Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Caris Life Sciences Major Business
Table 55. Caris Life Sciences Comprehensive Genomic Profiling Product and Services
Table 56. Caris Life Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Caris Life Sciences Recent Developments/Updates
Table 58. Caris Life Sciences Competitive Strengths & Weaknesses
Table 59. Tempus AI Basic Information, Manufacturing Base and Competitors
Table 60. Tempus AI Major Business
Table 61. Tempus AI Comprehensive Genomic Profiling Product and Services
Table 62. Tempus AI Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Tempus AI Recent Developments/Updates
Table 64. Tempus AI Competitive Strengths & Weaknesses
Table 65. Labcorp Basic Information, Manufacturing Base and Competitors
Table 66. Labcorp Major Business
Table 67. Labcorp Comprehensive Genomic Profiling Product and Services
Table 68. Labcorp Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Labcorp Recent Developments/Updates
Table 70. Labcorp Competitive Strengths & Weaknesses
Table 71. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 72. NeoGenomics Major Business
Table 73. NeoGenomics Comprehensive Genomic Profiling Product and Services
Table 74. NeoGenomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. NeoGenomics Recent Developments/Updates
Table 76. NeoGenomics Competitive Strengths & Weaknesses
Table 77. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 78. Exact Sciences Major Business
Table 79. Exact Sciences Comprehensive Genomic Profiling Product and Services
Table 80. Exact Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Exact Sciences Recent Developments/Updates
Table 82. Exact Sciences Competitive Strengths & Weaknesses
Table 83. Personalis Basic Information, Manufacturing Base and Competitors
Table 84. Personalis Major Business
Table 85. Personalis Comprehensive Genomic Profiling Product and Services
Table 86. Personalis Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Personalis Recent Developments/Updates
Table 88. Personalis Competitive Strengths & Weaknesses
Table 89. Illumina Basic Information, Manufacturing Base and Competitors
Table 90. Illumina Major Business
Table 91. Illumina Comprehensive Genomic Profiling Product and Services
Table 92. Illumina Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Illumina Recent Developments/Updates
Table 94. Illumina Competitive Strengths & Weaknesses
Table 95. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Comprehensive Genomic Profiling Product and Services
Table 98. Thermo Fisher Scientific Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 101. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 102. QIAGEN Major Business
Table 103. QIAGEN Comprehensive Genomic Profiling Product and Services
Table 104. QIAGEN Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. QIAGEN Recent Developments/Updates
Table 106. QIAGEN Competitive Strengths & Weaknesses
Table 107. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Agilent Technologies Major Business
Table 109. Agilent Technologies Comprehensive Genomic Profiling Product and Services
Table 110. Agilent Technologies Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Agilent Technologies Recent Developments/Updates
Table 112. Agilent Technologies Competitive Strengths & Weaknesses
Table 113. SOPHiA GENETICS Basic Information, Manufacturing Base and Competitors
Table 114. SOPHiA GENETICS Major Business
Table 115. SOPHiA GENETICS Comprehensive Genomic Profiling Product and Services
Table 116. SOPHiA GENETICS Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. SOPHiA GENETICS Recent Developments/Updates
Table 118. SOPHiA GENETICS Competitive Strengths & Weaknesses
Table 119. Sysmex Basic Information, Manufacturing Base and Competitors
Table 120. Sysmex Major Business
Table 121. Sysmex Comprehensive Genomic Profiling Product and Services
Table 122. Sysmex Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sysmex Recent Developments/Updates
Table 124. Sysmex Competitive Strengths & Weaknesses
Table 125. Burning Rock Biotech Basic Information, Manufacturing Base and Competitors
Table 126. Burning Rock Biotech Major Business
Table 127. Burning Rock Biotech Comprehensive Genomic Profiling Product and Services
Table 128. Burning Rock Biotech Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Burning Rock Biotech Recent Developments/Updates
Table 130. Burning Rock Biotech Competitive Strengths & Weaknesses
Table 131. Genetron Health Basic Information, Manufacturing Base and Competitors
Table 132. Genetron Health Major Business
Table 133. Genetron Health Comprehensive Genomic Profiling Product and Services
Table 134. Genetron Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Genetron Health Recent Developments/Updates
Table 136. Genetron Health Competitive Strengths & Weaknesses
Table 137. Geneseeq Basic Information, Manufacturing Base and Competitors
Table 138. Geneseeq Major Business
Table 139. Geneseeq Comprehensive Genomic Profiling Product and Services
Table 140. Geneseeq Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Geneseeq Recent Developments/Updates
Table 142. Geneseeq Competitive Strengths & Weaknesses
Table 143. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 144. BGI Genomics Major Business
Table 145. BGI Genomics Comprehensive Genomic Profiling Product and Services
Table 146. BGI Genomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. BGI Genomics Recent Developments/Updates
Table 148. BGI Genomics Competitive Strengths & Weaknesses
Table 149. Amoy Diagnostics Basic Information, Manufacturing Base and Competitors
Table 150. Amoy Diagnostics Major Business
Table 151. Amoy Diagnostics Comprehensive Genomic Profiling Product and Services
Table 152. Amoy Diagnostics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Amoy Diagnostics Recent Developments/Updates
Table 154. Amoy Diagnostics Competitive Strengths & Weaknesses
Table 155. Global Key Players of Comprehensive Genomic Profiling Upstream (Raw Materials)
Table 156. Global Comprehensive Genomic Profiling Typical Customers
Table 1. World Comprehensive Genomic Profiling Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Comprehensive Genomic Profiling Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Comprehensive Genomic Profiling Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Comprehensive Genomic Profiling Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Comprehensive Genomic Profiling Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Comprehensive Genomic Profiling Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Comprehensive Genomic Profiling Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Comprehensive Genomic Profiling Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Comprehensive Genomic Profiling Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Comprehensive Genomic Profiling Players in 2025
Table 12. World Comprehensive Genomic Profiling Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Comprehensive Genomic Profiling Company Evaluation Quadrant
Table 14. Head Office of Key Comprehensive Genomic Profiling Players
Table 15. Comprehensive Genomic Profiling Market: Company Product Type Footprint
Table 16. Comprehensive Genomic Profiling Market: Company Product Application Footprint
Table 17. Comprehensive Genomic Profiling Mergers & Acquisitions Activity
Table 18. United States VS China Comprehensive Genomic Profiling Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Comprehensive Genomic Profiling Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Comprehensive Genomic Profiling Companies, Headquarters (States, Country)
Table 21. United States Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 23. China Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
Table 24. China Based Companies Comprehensive Genomic Profiling Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 26. Rest of World Based Comprehensive Genomic Profiling Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Comprehensive Genomic Profiling Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Comprehensive Genomic Profiling Revenue Market Share (2021-2026)
Table 29. World Comprehensive Genomic Profiling Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Comprehensive Genomic Profiling Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Comprehensive Genomic Profiling Market Size by Type (2027-2032) & (USD Million)
Table 32. World Comprehensive Genomic Profiling Market Size by Testing Scope, (USD Million), 2021 & 2025 & 2032
Table 33. World Comprehensive Genomic Profiling Market Size Value by Testing Scope (2021-2026) & (USD Million)
Table 34. World Comprehensive Genomic Profiling Market Size by Testing Scope (2027-2032) & (USD Million)
Table 35. World Comprehensive Genomic Profiling Market Size by Sequencing Approach, (USD Million), 2021 & 2025 & 2032
Table 36. World Comprehensive Genomic Profiling Market Size Value by Sequencing Approach (2021-2026) & (USD Million)
Table 37. World Comprehensive Genomic Profiling Market Size by Sequencing Approach (2027-2032) & (USD Million)
Table 38. World Comprehensive Genomic Profiling Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Comprehensive Genomic Profiling Market Size by Application (2021-2026) & (USD Million)
Table 40. World Comprehensive Genomic Profiling Market Size by Application (2027-2032) & (USD Million)
Table 41. Roche Basic Information, Manufacturing Base and Competitors
Table 42. Roche Major Business
Table 43. Roche Comprehensive Genomic Profiling Product and Services
Table 44. Roche Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Roche Recent Developments/Updates
Table 46. Roche Competitive Strengths & Weaknesses
Table 47. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 48. Guardant Health Major Business
Table 49. Guardant Health Comprehensive Genomic Profiling Product and Services
Table 50. Guardant Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guardant Health Recent Developments/Updates
Table 52. Guardant Health Competitive Strengths & Weaknesses
Table 53. Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table 54. Caris Life Sciences Major Business
Table 55. Caris Life Sciences Comprehensive Genomic Profiling Product and Services
Table 56. Caris Life Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Caris Life Sciences Recent Developments/Updates
Table 58. Caris Life Sciences Competitive Strengths & Weaknesses
Table 59. Tempus AI Basic Information, Manufacturing Base and Competitors
Table 60. Tempus AI Major Business
Table 61. Tempus AI Comprehensive Genomic Profiling Product and Services
Table 62. Tempus AI Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Tempus AI Recent Developments/Updates
Table 64. Tempus AI Competitive Strengths & Weaknesses
Table 65. Labcorp Basic Information, Manufacturing Base and Competitors
Table 66. Labcorp Major Business
Table 67. Labcorp Comprehensive Genomic Profiling Product and Services
Table 68. Labcorp Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Labcorp Recent Developments/Updates
Table 70. Labcorp Competitive Strengths & Weaknesses
Table 71. NeoGenomics Basic Information, Manufacturing Base and Competitors
Table 72. NeoGenomics Major Business
Table 73. NeoGenomics Comprehensive Genomic Profiling Product and Services
Table 74. NeoGenomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. NeoGenomics Recent Developments/Updates
Table 76. NeoGenomics Competitive Strengths & Weaknesses
Table 77. Exact Sciences Basic Information, Manufacturing Base and Competitors
Table 78. Exact Sciences Major Business
Table 79. Exact Sciences Comprehensive Genomic Profiling Product and Services
Table 80. Exact Sciences Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Exact Sciences Recent Developments/Updates
Table 82. Exact Sciences Competitive Strengths & Weaknesses
Table 83. Personalis Basic Information, Manufacturing Base and Competitors
Table 84. Personalis Major Business
Table 85. Personalis Comprehensive Genomic Profiling Product and Services
Table 86. Personalis Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Personalis Recent Developments/Updates
Table 88. Personalis Competitive Strengths & Weaknesses
Table 89. Illumina Basic Information, Manufacturing Base and Competitors
Table 90. Illumina Major Business
Table 91. Illumina Comprehensive Genomic Profiling Product and Services
Table 92. Illumina Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Illumina Recent Developments/Updates
Table 94. Illumina Competitive Strengths & Weaknesses
Table 95. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 96. Thermo Fisher Scientific Major Business
Table 97. Thermo Fisher Scientific Comprehensive Genomic Profiling Product and Services
Table 98. Thermo Fisher Scientific Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Thermo Fisher Scientific Recent Developments/Updates
Table 100. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 101. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 102. QIAGEN Major Business
Table 103. QIAGEN Comprehensive Genomic Profiling Product and Services
Table 104. QIAGEN Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. QIAGEN Recent Developments/Updates
Table 106. QIAGEN Competitive Strengths & Weaknesses
Table 107. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Agilent Technologies Major Business
Table 109. Agilent Technologies Comprehensive Genomic Profiling Product and Services
Table 110. Agilent Technologies Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Agilent Technologies Recent Developments/Updates
Table 112. Agilent Technologies Competitive Strengths & Weaknesses
Table 113. SOPHiA GENETICS Basic Information, Manufacturing Base and Competitors
Table 114. SOPHiA GENETICS Major Business
Table 115. SOPHiA GENETICS Comprehensive Genomic Profiling Product and Services
Table 116. SOPHiA GENETICS Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. SOPHiA GENETICS Recent Developments/Updates
Table 118. SOPHiA GENETICS Competitive Strengths & Weaknesses
Table 119. Sysmex Basic Information, Manufacturing Base and Competitors
Table 120. Sysmex Major Business
Table 121. Sysmex Comprehensive Genomic Profiling Product and Services
Table 122. Sysmex Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sysmex Recent Developments/Updates
Table 124. Sysmex Competitive Strengths & Weaknesses
Table 125. Burning Rock Biotech Basic Information, Manufacturing Base and Competitors
Table 126. Burning Rock Biotech Major Business
Table 127. Burning Rock Biotech Comprehensive Genomic Profiling Product and Services
Table 128. Burning Rock Biotech Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Burning Rock Biotech Recent Developments/Updates
Table 130. Burning Rock Biotech Competitive Strengths & Weaknesses
Table 131. Genetron Health Basic Information, Manufacturing Base and Competitors
Table 132. Genetron Health Major Business
Table 133. Genetron Health Comprehensive Genomic Profiling Product and Services
Table 134. Genetron Health Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Genetron Health Recent Developments/Updates
Table 136. Genetron Health Competitive Strengths & Weaknesses
Table 137. Geneseeq Basic Information, Manufacturing Base and Competitors
Table 138. Geneseeq Major Business
Table 139. Geneseeq Comprehensive Genomic Profiling Product and Services
Table 140. Geneseeq Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Geneseeq Recent Developments/Updates
Table 142. Geneseeq Competitive Strengths & Weaknesses
Table 143. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 144. BGI Genomics Major Business
Table 145. BGI Genomics Comprehensive Genomic Profiling Product and Services
Table 146. BGI Genomics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. BGI Genomics Recent Developments/Updates
Table 148. BGI Genomics Competitive Strengths & Weaknesses
Table 149. Amoy Diagnostics Basic Information, Manufacturing Base and Competitors
Table 150. Amoy Diagnostics Major Business
Table 151. Amoy Diagnostics Comprehensive Genomic Profiling Product and Services
Table 152. Amoy Diagnostics Comprehensive Genomic Profiling Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Amoy Diagnostics Recent Developments/Updates
Table 154. Amoy Diagnostics Competitive Strengths & Weaknesses
Table 155. Global Key Players of Comprehensive Genomic Profiling Upstream (Raw Materials)
Table 156. Global Comprehensive Genomic Profiling Typical Customers
LIST OF FIGURES
Figure 1. Comprehensive Genomic Profiling Picture
Figure 2. World Comprehensive Genomic Profiling Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Comprehensive Genomic Profiling Total Revenue (2021-2032) & (USD Million)
Figure 4. World Comprehensive Genomic Profiling Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Comprehensive Genomic Profiling Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 13. Comprehensive Genomic Profiling Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 16. World Comprehensive Genomic Profiling Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 18. China Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 23. India Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Comprehensive Genomic Profiling by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Comprehensive Genomic Profiling Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Comprehensive Genomic Profiling Markets in 2025
Figure 27. United States VS China: Comprehensive Genomic Profiling Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Comprehensive Genomic Profiling Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Comprehensive Genomic Profiling Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Comprehensive Genomic Profiling Market Size Market Share by Type in 2025
Figure 31. Tissue-based Profiling
Figure 32. Liquid Biopsy Profiling
Figure 33. Other
Figure 34. World Comprehensive Genomic Profiling Market Size Market Share by Type (2021-2032)
Figure 35. World Comprehensive Genomic Profiling Market Size by Testing Scope, (USD Million), 2021 & 2025 & 2032
Figure 36. World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope in 2025
Figure 37. Medium Panels (50?199 Genes)
Figure 38. Large Panels (200?599 Genes)
Figure 39. Extended Panels (600?999 Genes)
Figure 40. Other
Figure 41. World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope (2021-2032)
Figure 42. World Comprehensive Genomic Profiling Market Size by Sequencing Approach, (USD Million), 2021 & 2025 & 2032
Figure 43. World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach in 2025
Figure 44. Targeted DNA Sequencing
Figure 45. Integrated DNA and RNA Sequencing
Figure 46. Whole-exome Sequencing
Figure 47. Whole-transcriptome Sequencing
Figure 48. Other
Figure 49. World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach (2021-2032)
Figure 50. World Comprehensive Genomic Profiling Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Comprehensive Genomic Profiling Market Size Market Share by Application in 2025
Figure 52. Hospitals and Cancer Centers
Figure 53. Independent Clinical Laboratories
Figure 54. Pharmaceutical and Biotechnology Companies
Figure 55. Other
Figure 56. World Comprehensive Genomic Profiling Market Size Market Share by Application (2021-2032)
Figure 57. Comprehensive Genomic Profiling Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Comprehensive Genomic Profiling Picture
Figure 2. World Comprehensive Genomic Profiling Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Comprehensive Genomic Profiling Total Revenue (2021-2032) & (USD Million)
Figure 4. World Comprehensive Genomic Profiling Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Comprehensive Genomic Profiling Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Comprehensive Genomic Profiling Revenue (2021-2032) & (USD Million)
Figure 13. Comprehensive Genomic Profiling Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 16. World Comprehensive Genomic Profiling Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 18. China Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 23. India Comprehensive Genomic Profiling Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Comprehensive Genomic Profiling by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Comprehensive Genomic Profiling Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Comprehensive Genomic Profiling Markets in 2025
Figure 27. United States VS China: Comprehensive Genomic Profiling Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Comprehensive Genomic Profiling Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Comprehensive Genomic Profiling Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Comprehensive Genomic Profiling Market Size Market Share by Type in 2025
Figure 31. Tissue-based Profiling
Figure 32. Liquid Biopsy Profiling
Figure 33. Other
Figure 34. World Comprehensive Genomic Profiling Market Size Market Share by Type (2021-2032)
Figure 35. World Comprehensive Genomic Profiling Market Size by Testing Scope, (USD Million), 2021 & 2025 & 2032
Figure 36. World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope in 2025
Figure 37. Medium Panels (50?199 Genes)
Figure 38. Large Panels (200?599 Genes)
Figure 39. Extended Panels (600?999 Genes)
Figure 40. Other
Figure 41. World Comprehensive Genomic Profiling Market Size Market Share by Testing Scope (2021-2032)
Figure 42. World Comprehensive Genomic Profiling Market Size by Sequencing Approach, (USD Million), 2021 & 2025 & 2032
Figure 43. World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach in 2025
Figure 44. Targeted DNA Sequencing
Figure 45. Integrated DNA and RNA Sequencing
Figure 46. Whole-exome Sequencing
Figure 47. Whole-transcriptome Sequencing
Figure 48. Other
Figure 49. World Comprehensive Genomic Profiling Market Size Market Share by Sequencing Approach (2021-2032)
Figure 50. World Comprehensive Genomic Profiling Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Comprehensive Genomic Profiling Market Size Market Share by Application in 2025
Figure 52. Hospitals and Cancer Centers
Figure 53. Independent Clinical Laboratories
Figure 54. Pharmaceutical and Biotechnology Companies
Figure 55. Other
Figure 56. World Comprehensive Genomic Profiling Market Size Market Share by Application (2021-2032)
Figure 57. Comprehensive Genomic Profiling Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
